Genen­tech gains clin­i­cal de­vel­op­ment ex­ec by ap­point­ing Lil­li Petruzzel­li; Paul Sekhri caps event­ful week, nam­ing Sap­na Sri­vas­ta­va CFO of eGe­n­e­sis

→ A spokesper­son for Genen­tech tells End­points News that Lil­li Petruzzel­li has forged a new path this week as SVP, ear­ly clin­i­cal de­vel­op­ment at Genen­tech’s Re­search and Ear­ly De­vel­op­ment or­ga­ni­za­tion (gRED). Petruzzel­li just spent two years as In­cyte’s group VP, ear­ly clin­i­cal de­vel­op­ment, and pri­or to In­cyte, she was glob­al head, trans­la­tion­al clin­i­cal on­col­o­gy at the No­var­tis In­sti­tutes of Bio­med­ical Re­search.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER